WASHINGTON, DC — The U.S. Food and Drug Administration has designated a major Class II recall involving more than 4.8 million cartons of eye drops sold nationwide, citing a lack of assurance of sterility. The action, announced Oct. 5, covers 27 brands and includes many store-label products that consumers may have picked up at large retailers.
The FDA said the recall matters because the manufacturer cannot guarantee the affected drops are sterile. The agency defines a Class II recall as one in which use of the product may cause temporary or medically reversible health problems, or where the chance of serious harm is remote.
Retail brands from Walmart, Target, Walgreens and grocery chains are included
The recalled products span several familiar private-label and national-name brands. Among the labels listed are Walgreens, Kroger, Publix, Harris Teeter, Good Sense, Clear Eyes, and Target’s up&up, along with products sold under brands such as Best Choice, Leader, and TopCare Health.
Many of the affected drops were sold in 0.5-fluid-ounce bottles. The FDA said consumers should check the brand name, UPC or NDC code, and the lot number and expiration date listed in the agency’s recall report to determine whether a bottle is included.
The recall includes products marketed for artificial tears, dryness relief, redness relief, and more advanced or high-performance lubricating formulas. That broad mix means shoppers may find the affected items in medicine cabinets, handbags, desk drawers, and travel kits rather than just in one type of eye-care section.
The largest recalled category is Maximum Redness Relief eye drops
By far the biggest category in the recall is Maximum Redness Relief Eye Drops, with 1,435,830 cartons affected. That group includes products sold under Exchange Select, Harris Teeter, Tyson Mike Red Eye Drops, up&up, TopCare Health, and Walgreens labels.
Other large categories include Sterile Lubricant Dry Eye Relief Eye Drops, with 1,327,248 cartons, and Original Redness Reliever Eye Drops, with 1,025,448 cartons. The FDA also listed 505,896 cartons of Artificial Tears Sterile Lubricant Eye Drops and 208,896 cartons of Sterile Eye Drops Advanced Relief.
Smaller but still significant recalls include 182,016 cartons of Sterile Eye Drops AC and 163,008 cartons of Sterile High Performance Ultra Lubricating Eye Drops. One product, Sterile Eye Drops Redness Relief, was also included, though the FDA did not report a total quantity for that line.
Consumers are being told to compare brand names and product codes
The FDA’s list is extensive because the same base products were distributed under multiple store brands. For example, Artificial Tears Sterile Lubricant Eye Drops were sold as Best Choice, Leader, Good Neighbor Pharmacy, Good Sense, Medic’s Choice, Publix, Quality Choice, TopCare Health, Walgreens and Kroger.
Sterile Eye Drops AC also appeared under Equaline, Good Sense, H-E-B, Quality Choice and TopCare Health. Sterile Eye Drops Advanced Relief was sold through brands including Leader, Equaline, Good Sense, H-E-B, Medic’s Choice, Foster & Thrive, Publix, Quality Choice and TopCare Health.
Because of that overlap, the FDA is directing consumers to verify the exact UPC or NDC code on each carton or bottle. The agency says its full recall report includes the lot numbers and expiration dates needed to match specific products.
K.C. Pharmaceuticals is the recalling firm after earlier FDA scrutiny
The recalling company is K.C. Pharmaceuticals, Inc., based in California. The FDA has previously scrutinized the firm’s manufacturing practices, including in an August 2026 warning letter that followed an inspection.
According to the FDA, that inspection found problems including inadequate procedures to prevent contamination of sterile products. The sterility concern tied to the current recall is therefore part of a broader compliance issue that regulators have already flagged.
For consumers, the practical takeaway is straightforward: if an eye drop bottle or carton appears on the FDA’s list, it should be treated as part of the recall. The agency’s classification indicates the risk is usually temporary or medically reversible, but the affected products are still considered unsafe to use as sold.
The recall adds to a string of recent eye drop safety actions
This recall is the third in recent weeks involving eye drop sterility concerns, according to the FDA-linked reporting. CVS announced a recall of Clear Eyes eye drops in mid-September, and another Walgreens eye drop recall was reported less than a week later.
The repeated actions suggest that sterility controls remain a sensitive issue in the eye-care market. Eye drops are used directly on a vulnerable area of the body, so contamination concerns tend to draw close attention from regulators and consumers alike.
For anyone who relies on artificial tears, redness relief or dry-eye products, the FDA’s message is to check packaging carefully rather than assume a familiar brand is unaffected. The current recall covers dozens of label variations, but it is tied to a single manufacturing firm and a shared sterility concern.
Leave a Reply